Global In Vitro Diagnostics (IVD) Quality Control Market Giants Spending Is Going to Boom

In Vitro Diagnostics (IVD) Quality Control Market Size And Forecast

In Vitro Diagnostics (IVD) Quality Control Market size was valued at USD 686.78 Million in 2023 and is projected to reach USD 1150.36 Million by 2031, growing at a CAGR of 6.66% from 2024 to 2031.

• In Vitro Diagnostics (IVD) quality control refers to the set of procedures and processes used to ensure the accuracy, reliability, and consistency of diagnostic tests performed outside of a living organism, typically in a laboratory setting. These controls are used to monitor and verify the performance of IVD devices, such as instruments, reagents, and test kits, ensuring that the results they produce are accurate and reproducible.
• In clinical laboratories, it validates routine and specialized tests like blood tests, urinalysis, and genetic screening.
• In hospitals and medical centers, it maintains the quality of point-of-care testing devices for rapid diagnostics, infection control, and chronic disease management. Research institutions rely on it to support clinical trials, biomarker discovery, and the validation of new diagnostic methods.
• Diagnostic manufacturers use quality control to ensure their products meet regulatory standards and performance criteria before market release.
• It helps laboratories comply with regulatory requirements through certification and routine audits, and is crucial for the reliability of point-of-care testing in home diagnostics, remote health, and field conditions.
• The development of new diagnostic technologies, including molecular diagnostics, next-generation sequencing, and digital pathology, will require advanced quality control measures to ensure their accuracy and reliability.

Global In Vitro Diagnostics (IVD) Quality Control Market Dynamics

The key market dynamics that are shaping the global In Vitro Diagnostics (IVD) Quality Control Market include:

Key Market Drivers:

• Increasing Demand for Accurate Diagnostic Tests: The rising prevalence of chronic diseases and infectious conditions worldwide fuels the demand for accurate and reliable diagnostic tests. Robust quality control measures are essential to ensure the accuracy and precision of these tests, driving the growth of the IVD quality control market.
• Technological Advancements in Diagnostics: Advancements in diagnostic technologies like molecular diagnostics, next-generation sequencing, and point-of-care testing necessitate advanced quality control solutions, especially with the rise of automation, robotics, and AI.
• Upsurge in Adoption of Point-of-Care Testing (POCT): The increasing use of point-of-care testing (POCT) in healthcare settings necessitates the development of quality control solutions to ensure accurate, reliable, and reproducible results in non-traditional settings.
• Expansion of Diagnostic Laboratories: The global expansion of diagnostic laboratory networks, particularly in emerging markets, is driving a growing demand for quality control products and services to standardize procedures and maintain high-quality results.
• Rising Focus on Personalized Medicine: The shift towards personalized medicine and precision diagnostics necessitates accurate, reliable tests tailored to individual patient characteristics, driving the adoption of quality control solutions in the IVD market.

Key Challenges:

• Complexity of Diagnostic Technologies: The complexity of diagnostic tests has increased due to advancements in molecular diagnostics and next-generation sequencing, making quality control measures more challenging due to their diverse nature and specialized expertise.
• Regulatory Compliance Burden: Manufacturers of quality control products face challenges in meeting FDA, EMA, and ISO regulations, requiring continuous investment in research, development, and quality assurance, increasing the cost and complexity of product delivery.
• Variability in Test Performance: Inherent variability in test performance, arising from factors such as sample type, operator technique, and environmental conditions, poses challenges for maintaining consistent test results across different laboratories and testing sites. Quality control measures must address this variability to ensure the accuracy and reliability of diagnostic tests.
• Emerging Infectious Diseases and Pandemics: Emerging infectious diseases and global pandemics like COVID-19 strain diagnostic testing infrastructure, necessitating rigorous quality control for test accuracy and reliability, thereby hindering market growth due to rapid development and deployment.
• Resource Constraints in Healthcare Settings: Limited resources in healthcare, especially in low- and middle-income countries, hinder robust quality control measures, making it crucial to address these constraints for global high-quality diagnostic testing accessibility.

Key Trends:

• Quality Management Systems (QMS): The adoption of quality management systems, including ISO 9001 and ISO 13485, is becoming increasingly prevalent in the IVD industry. Quality control solutions that integrate with QMS platforms to automate processes, document compliance, and track performance metrics are in high demand.
• Demand for Comprehensive Solutions: There is a growing demand for comprehensive quality control solutions that encompass a wide range of parameters, including instrument calibration, reagent validation, operator training, and proficiency testing. Integrated quality control platforms that offer end-to-end solutions are gaining traction in the market.
• Emphasis on Data Analytics and Predictive Maintenance: Data analytics and predictive maintenance techniques are being leveraged to optimize quality control processes, identify trends, and prevent potential issues before they occur. Predictive analytics algorithms help forecast instrument performance, detect anomalies, and optimize maintenance schedules, enhancing overall quality assurance.
• Focus on Laboratory Efficiency and Productivity: Efficiency and productivity improvements are driving the adoption of automated quality control solutions that streamline workflows, reduce manual intervention, and minimize downtime. Integrated quality control systems that seamlessly interface with laboratory information management systems (LIMS) are essential for enhancing laboratory efficiency.

Global In Vitro Diagnostics (IVD) Quality Control Market Regional Analysis

Here is a more detailed regional analysis of the global In Vitro Diagnostics (IVD) Quality Control Market:

North America:

• North America dominates the IVD quality control market due to the presence of a well-established healthcare infrastructure, stringent regulatory requirements, and high adoption of advanced diagnostic technologies.
• The region is characterized by a strong emphasis on quality assurance and compliance, driving the demand for sophisticated quality control solutions.
• Increasing adoption of automated quality control systems in clinical laboratories and diagnostic facilities.
• Growing demand for personalized medicine and precision diagnostics, driving the need for tailored quality control solutions.

Europe:

• Europe is a significant market for IVD quality control, driven by robust healthcare systems, technological advancements, and favorable regulatory environment.
• The region’s focus on standardization and harmonization of quality control practices contributes to market growth.
• Emphasis on regulatory compliance and adherence to ISO standards for quality management.
• Rising adoption of digitalization and connectivity solutions for remote monitoring and quality assurance.

Asia Pacific:

• Asia Pacific is the fastest-growing region in the IVD quality control market, driven by the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and rising demand for advanced diagnostic technologies.
• Rapid economic development and government initiatives to improve healthcare access and quality contribute to market growth.
• Adoption of point-of-care testing (POCT) and decentralized diagnostic solutions, driving demand for portable and user-friendly quality control solutions.
• Growing investment in research and development, leading to technological advancements in quality control products and services.

Global In Vitro Diagnostics (IVD) Quality Control Market: Segmentation Analysis

The Global In Vitro Diagnostics (IVD) Quality Control Market is Segmented on the basis of Products & Services, Application, and Geography.

In Vitro Diagnostics (IVD) Quality Control Market, By Products & Services

• Quality Control Products
• Data Management Solutions

Based on Products & Services, the market is divided into Quality Control Products, and Data Management Solutions. In the In Vitro Diagnostics (IVD) Quality Control Market, quality control products segment dominates due to the essential role they play in ensuring the accuracy and reliability of diagnostic tests. Quality control products include calibration materials, controls, standards, and proficiency testing materials, which are indispensable for validating and monitoring the performance of diagnostic instruments and assays. On the other hand, data management solutions emerge as the second rapidly growing segment, driven by the increasing adoption of digitalization, automation, and connectivity in laboratory workflows. These solutions offer features such as remote monitoring, data analysis, and compliance management, facilitating efficient quality assurance processes and enhancing laboratory productivity and compliance.

In Vitro Diagnostics (IVD) Quality Control Market, By Application

• Infectious Diseases
• Oncology
• Cardiology
• Autoimmune Disorders

Based on Application, the In Vitro Diagnostics (IVD) Quality Control Market is classified into Oncology, Cardiology, Autoimmune Disorders, and Infectious Diseases. The oncology is emerging as the dominating application segment, driven by the increasing prevalence of cancer worldwide and the growing demand for accurate and reliable diagnostic tests for cancer detection, monitoring, and treatment. Quality control measures are crucial in oncology diagnostics to ensure the accuracy and consistency of tests such as tumor marker assays, molecular diagnostics, and imaging tests. Infectious diseases represent the second rapidly growing application segment, fueled by the global burden of infectious diseases and the urgent need for effective diagnostic testing, especially in the context of emerging pathogens and pandemics like COVID-19. Quality control solutions play a vital role in infectious disease diagnostics to validate test performance, monitor assay accuracy, and ensure timely and accurate detection of infectious agents.

Key Players

The “Global In Vitro Diagnostics (IVD) Quality Control Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Bio-Rad Laboratories, Danaher Corporation, Helena Laboratories, LGC Limited, Randox Laboratories, Roche Diagnostics, Siemens Healthineers, SeraCare Life Sciences, Sysmex Corporation. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

In Vitro Diagnostics (IVD) Quality Control Market Recent Developments

• In June 2023, Randox Laboratories Ltd has acquired Celi Limited to expand its personalized medicine market and enhance preventative healthcare.
• In March 2023, SeraCare Life Sciences Inc. has released Seraseq BRCA1/2 reference materials to meet clinical laboratory testing needs for somatic and germline levels.
• In November 2023, Merck KGaA has introduced ChemisTwin, a digital reference system designed to analyze the purity, identification, and degradation of compounds in samples.
• In May 2023, ZeptoMetrix has introduced PROLrol, a new line of quality control products for antigen-based diagnostics methods, including the lateral flow immunoassay for infectious diseases.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.